Company Filing History:
Years Active: 2003-2006
Title: Clothilde Thiriart: Innovator in Vaccine Development
Introduction
Clothilde Thiriart, an esteemed inventor based in Brussels, Belgium, has made significant contributions to the field of vaccine development. With a total of three patents to her name, she continues to push the boundaries of medical science, particularly in the creation of innovative vaccine formulations.
Latest Patents
Thiriart's latest inventions focus on novel vaccine compositions aimed at combatting hepatitis. One of her key contributions includes a composition comprising a hepatitis B antigen formulated with aluminium phosphate. This formulation may further include an inactivated hepatitis A virus, aluminium hydroxide, and formol, allowing for a combined hepatitis A and B vaccine that can be administered in a two-dose regimen. Additionally, she has developed vaccine formulations that incorporate 3-O-deacylated monophosphoryl lipid A, presenting a treatment or prophylaxis option for hepatitis B infections. These groundbreaking vaccine formulations represent significant advancements in the fight against viral infections.
Career Highlights
Clothilde Thiriart has been affiliated with SmithKline Beecham Biologicals S.A., a company renowned for its commitment to research and development in the pharmaceutical industry. Her work at this leading organization showcases her dedication to improving public health through innovative scientific research.
Collaborations
Throughout her career, Thiriart has collaborated with esteemed colleagues including Nathalie Marie-Josephe Claude Garcon-Johnson and Pierre Hauser. These professional relationships underline her commitment to collaborative research and the sharing of ideas necessary for innovative breakthroughs in vaccine technology.
Conclusion
In conclusion, Clothilde Thiriart stands out as a prominent inventor in the field of vaccine development. Her contributions, highlighted by her patents, reflect her innovative spirit and dedication to enhancing human health. With ongoing advancements in her work, Thiriart plays a crucial role in the future of vaccine formulations.